Pharmaids [PHARMAID] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Pharmaids

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharmaids wins in 3 metrics, Sun Pharmaceutical wins in 15 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricPharmaidsSun PharmaceuticalBetter
P/E Ratio (TTM)2,023.3337.73Sun Pharmaceutical
Price-to-Book Ratio3.355.42Pharmaids
Debt-to-Equity Ratio70.813.26Sun Pharmaceutical
PEG Ratio23.66-1.94Sun Pharmaceutical
EV/EBITDA-16.2223.98Pharmaids
Profit Margin (TTM)-61.01%19.29%Sun Pharmaceutical
Operating Margin (TTM)-90.28%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)N/A24.34%N/A
Return on Equity-19.58%15.08%Sun Pharmaceutical
Return on Assets (TTM)-8.99%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$-264.72M$119.44BSun Pharmaceutical
Dividend YieldN/A1.26%N/A
1-Year Return30.67%-13.08%Pharmaids
Price-to-Sales Ratio (TTM)9.257.28Sun Pharmaceutical
Enterprise Value$2.35B$3,678.87BSun Pharmaceutical
EV/Revenue Ratio10.986.84Sun Pharmaceutical
Gross Profit Margin (TTM)47.39%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$6$224Sun Pharmaceutical
Earnings per Share (Diluted)$-3.71$43.23Sun Pharmaceutical
Beta (Stock Volatility)0.530.28Sun Pharmaceutical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Pharmaids vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Pharmaids
Sun Pharmaceutical
Pharmaids Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids-5.46%-12.16%-14.88%-8.85%-19.65%-29.42%
Sun Pharmaceutical-1.30%3.69%4.56%-1.60%-0.80%-12.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids30.67%281.24%550.44%1,134.75%1,482.73%125.13%
Sun Pharmaceutical-13.08%69.32%239.52%85.64%710.50%2,595.42%

News Based Sentiment: Pharmaids vs Sun Pharmaceutical

Pharmaids

News based Sentiment: MIXED

September brought substantial changes to Pharmaids Pharmaceuticals, including a major divestiture and an ongoing open offer, alongside continued financial difficulties. These events create both opportunities and risks for investors, making it a significant month for the company's trajectory. The mixed signals from insider trading add to the complexity of the investment picture.

View Pharmaids News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a month of significant contrasts for Sun Pharma. While the company demonstrated revenue growth and made strategic acquisitions, the imposition of a 100% US tariff on Indian pharmaceuticals presents a major headwind. This combination of positive and negative developments creates a mixed investment outlook.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Pharmaids vs Sun Pharmaceutical

MetricPHARMAIDSUNPHARMA
Market Information
Market Cap i₹1.98B₹4.01T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i4,9893,168,435
90 Day Avg. Volume i4,9372,778,768
Last Close₹49.38₹1,631.60
52 Week Range₹45.50 - ₹84.97₹1,548.00 - ₹1,947.00
% from 52W High-41.89%-16.20%
All-Time High₹87.46 (Nov 11, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-43.54%-16.77%
Growth Metrics
Quarterly Revenue Growth0.43%0.10%
Quarterly Earnings Growth0.43%-0.20%
Financial Health
Profit Margin (TTM) i-0.61%0.19%
Operating Margin (TTM) i-0.90%0.24%
Return on Equity (TTM) i-0.20%0.15%
Debt to Equity (MRQ) i70.813.26
Cash & Liquidity
Book Value per Share (MRQ)₹16.72₹300.99
Cash per Share (MRQ)₹0.61₹108.88
Operating Cash Flow (TTM) i₹-278,094,000₹110.84B
Levered Free Cash Flow (TTM) i₹-107,766,000₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A1.26%
Last 12-Month Dividend iN/A₹21.00

Valuation & Enterprise Metrics Analysis: Pharmaids vs Sun Pharmaceutical

MetricPHARMAIDSUNPHARMA
Price Ratios
P/E Ratio (TTM) i2,023.3337.73
Forward P/E iN/A49.91
PEG Ratio i23.66-1.94
Price to Sales (TTM) i9.257.28
Price to Book (MRQ) i3.355.42
Market Capitalization
Market Capitalization i₹1.98B₹4.01T
Enterprise Value i₹2.35B₹3.68T
Enterprise Value Metrics
Enterprise to Revenue i10.986.84
Enterprise to EBITDA i-16.2223.98
Risk & Other Metrics
Beta i0.530.28
Book Value per Share (MRQ) i₹16.72₹300.99

Financial Statements Comparison: Pharmaids vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PHARMAIDSUNPHARMA
Revenue/Sales i₹66.64M₹137.86B
Cost of Goods Sold i₹35.06M₹28.15B
Gross Profit i₹31.58M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-60.16M₹33.72B
EBITDA i₹-53.69M₹47.66B
Pre-Tax Income i₹-71.71M₹31.73B
Income Tax i₹-18.56M₹8.70B
Net Income (Profit) i₹-53.15M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PHARMAIDSUNPHARMA
Cash & Equivalents i₹21.45M₹102.69B
Total Current Assets i₹223.07M₹526.24B
Total Current Liabilities i₹287.15M₹181.94B
Long-Term Debt i₹331.19M₹3.58B
Total Shareholders Equity i₹550.42M₹724.86B
Retained Earnings i₹-266.77M₹578.62B
Property, Plant & Equipment i₹19.32M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PHARMAIDSUNPHARMA
Operating Cash Flow i₹-1.10MN/A
Capital Expenditures i₹0N/A
Free Cash Flow i₹2.39MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i4,9893,168,435
Average Daily Volume (90 Day) i4,9372,778,768
Shares Outstanding i35.27M2.40B
Float Shares i5.78M1.06B
% Held by Insiders i0.77%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Pharmaids vs Sun Pharmaceutical

MetricPHARMAIDSUNPHARMA
Last 12-Month Dividend iN/A₹21.00
Last 12-Month Dividend Yield iN/A1.26%
3-Year Avg Annual Dividend iN/A₹14.67
3-Year Avg Dividend Yield iN/A0.46%
3-Year Total Dividends iN/A₹44.00
Ex-Dividend DateN/AJul 07, 2025